reviewTop 1% cited
Clinical and economic consequences of ventilator-associated pneumonia: A systematic review
Critical Care Medicine · 2005 · Vol. 33(10) · pp. 2184–2193
Nasia Safdar✉(University of California, San Francisco)Cameron Dezfulian(National Institutes of Health)Harold R. Collard(National Institutes of Health)Sanjay Saint(Johns Hopkins Hospital)
Abstract
Ventilator-associated pneumonia occurs in a considerable proportion of patients undergoing mechanical ventilation and is associated with substantial morbidity, a two-fold mortality rate, and excess cost. Given these findings, strategies that effectively prevent VAP are urgently needed.
Nosocomial Infections in ICUInhalation and Respiratory Drug DeliveryPneumonia and Respiratory InfectionsMedicineVentilator-associated pneumoniaMechanical ventilationIntensive care unitConfidence intervalOdds ratioRate ratioPneumoniaIncidence (geometry)Intensive care
MeSH terms
Critical CareCross InfectionHumansLength of StayPneumoniaRespiration, ArtificialIncidenceHealth Care Costs
Citations
1,097
FWCI
35.10
field-weighted impact
References
133
Percentile
100%
vs. same field & year
Citations per year
Cited by
Antimicrobial resistance patterns in ventilator-associated pneumonia (VAP) in ICU Patients
International Journal of Advanced Research in Medicine · 2019 · 0 citations
References
Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit
Intensive Care Medicine · 1996 · 655 citations
Epidemiology and Outcomes of Ventilator-Associated Pneumonia in a Large US Database
CHEST Journal · 2002 · 1,303 citations
Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
The American Journal of Medicine · 1993 · 1,192 citations
Ventilator-associated Pneumonia
American Journal of Respiratory and Critical Care Medicine · 2002 · 2,804 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
